Back to Journals » Cancer Management and Research » Volume 12

RETRACTED ARTICLE: Oncolytic Vaccinia Virus-Mediated Antitumor Effect and Cell Proliferation Were Promoted in PTC by Regulating circRNA_103598/miR-23a-3p/IL-6 Axis

Authors Zhang S, Wang Q, Li D, Huang B, Hou X, Wang D, Xiao Z, Meng H, Zhang Y, Dong L

Received 4 August 2020

Accepted for publication 28 September 2020

Published 20 October 2020 Volume 2020:12 Pages 10389—10396

DOI https://doi.org/10.2147/CMAR.S273072

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Eileen O'Reilly



This paper has been retracted.

Zhang S, Wang Q, Li D, et al. Cancer Manag Res. 2020;12:10389–10396.

We, the Editors and Publisher of Cancer Management and Research, have retracted the following article.

Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors did not respond to our queries, nor did they provide original data for their study. As verifying the validity of the published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.